Condensed Consolidated Statements of Changes in Stockholders’ Deficit - USD ($) shares in Thousands, $ in Thousands	Total	Issuance of new common stock in connection with emergence	Issuance of new common stock under the Equity Rights Offering	Issuance of new common stock for the Equity Rights Offering backstop commitment	Issuance of new common stock for Bitmain obligation	Cumulative Effect, Period of Adoption, Adjustment	Cumulative Effect, Period of Adoption, Adjusted Balance	Common Stock	Common Stock Issuance of new common stock in connection with emergence	Common Stock Issuance of new common stock under the Equity Rights Offering	Common Stock Issuance of new common stock for the Equity Rights Offering backstop commitment	Common Stock Issuance of new common stock for Bitmain obligation	Common Stock Cumulative Effect, Period of Adoption, Adjusted Balance	Additional Paid-In Capital	Additional Paid-In Capital Issuance of new common stock in connection with emergence	Additional Paid-In Capital Issuance of new common stock under the Equity Rights Offering	Additional Paid-In Capital Issuance of new common stock for the Equity Rights Offering backstop commitment	Additional Paid-In Capital Issuance of new common stock for Bitmain obligation	Additional Paid-In Capital Cumulative Effect, Period of Adoption, Adjusted Balance	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning balance (in shares) at Dec. 31, 2023								386,883					386,883
Beginning balance at Dec. 31, 2023	$ (596,941)					$ 24	$ (596,917)	$ 36					$ 36	$ 1,823,260					$ 1,823,260	$ (2,420,237)	$ 24	$ (2,420,213)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(1,146,725)																			(1,146,725)
Stock-based compensation	27,957													27,957
Cancellation of common stock in connection with emergence (in shares)								(386,883)
Cancellation of common stock in connection with emergence	0							$ (36)						36
Issuance of new common stock (in shares)									152,576	15,649	2,111	10,735
Issuance of new common stock		$ 296,895	$ 55,000	$ 5,475	$ 27,839				$ 2						$ 296,893	$ 55,000	$ 5,475	$ 27,839
Conversion premium on the issuance of the New Secured Convertible Notes	33,202													33,202
Issuance of warrants	(345,856)													(345,856)
Exercise of stock options	9													9
Restricted stock awards issued, net of tax withholding obligations (in shares)								1,624
Restricted stock awards issued, net of tax withholding obligations	(3,390)													(3,390)
Restricted stock awards forfeited (in shares)								(40)
Exercise of warrants (in shares)								51,699
Exercise of warrants	554,406							$ 1						554,405
Issuance of new common stock for New Secured Convertible Notes conversion (in shares)								44,585
Issuance of new common stock for New Secured Convertible Notes conversion	261,772													261,772
Issuance of new common stock for PIK interest (in shares)								882
Issuance of new common stock for PIK interest	3,677													3,677
Ending balance (in shares) at Sep. 30, 2024								279,821
Ending balance at Sep. 30, 2024	(826,656)							$ 3						2,740,279						(3,566,938)
Beginning balance (in shares) at Jun. 30, 2024								187,892
Beginning balance at Jun. 30, 2024	(1,181,135)							$ 2						1,930,542						(3,111,679)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(455,259)																			(455,259)
Stock-based compensation	20,523													20,523
Restricted stock awards issued, net of tax withholding obligations (in shares)								224
Restricted stock awards issued, net of tax withholding obligations	2													2
Exercise of warrants (in shares)								51,645
Exercise of warrants	553,986							$ 1						553,985
Issuance of new common stock for New Secured Convertible Notes conversion (in shares)								40,060
Issuance of new common stock for New Secured Convertible Notes conversion	235,227													235,227
Ending balance (in shares) at Sep. 30, 2024								279,821
Ending balance at Sep. 30, 2024	$ (826,656)							$ 3						2,740,279						(3,566,938)
Beginning balance (in shares) at Dec. 31, 2024	292,606							292,606
Beginning balance at Dec. 31, 2024	$ (943,049)							$ 3						2,915,035						(3,858,087)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(504,575)																			(504,575)
Stock-based compensation	70,924													70,924
Restricted stock awards issued (in shares)								6,108
Restricted stock awards issued	(16)													(16)
Restricted stock awards withheld for tax withholding obligations (in shares)								(585)
Restricted stock awards withheld for tax withholding obligations	(9,722)													(9,722)
Equity issuance costs	(21)													(21)
Exercise of warrants (in shares)								10,252
Exercise of warrants	$ 133,821													133,821
Ending balance (in shares) at Sep. 30, 2025	308,381							308,381
Ending balance at Sep. 30, 2025	$ (1,252,638)							$ 3						3,110,021						(4,362,662)
Beginning balance (in shares) at Jun. 30, 2025								303,146
Beginning balance at Jun. 30, 2025	(1,191,987)							$ 3						3,026,645						(4,218,635)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(144,027)																			(144,027)
Stock-based compensation	30,173													30,173
Restricted stock awards issued (in shares)								1,629
Restricted stock awards issued	34													34
Restricted stock awards withheld for tax withholding obligations (in shares)								(585)
Restricted stock awards withheld for tax withholding obligations	(9,722)													(9,722)
Exercise of warrants (in shares)								4,191
Exercise of warrants	$ 62,891													62,891
Ending balance (in shares) at Sep. 30, 2025	308,381							308,381
Ending balance at Sep. 30, 2025	$ (1,252,638)							$ 3						$ 3,110,021						$ (4,362,662)